FDA Approves First Oral Medication for Lupus Nephritis

FDA Approves First Oral Medication for Lupus Nephritis

The U.S. Food and Drug Administration (FDA) announced on Friday (1/22) the first ever approval for Aurinia Pharmaceutical’s Lupkynis oral medication in combination with a background immunosuppressive therapy regimen for lupus nephritis (LN), serious chronic autoimmune...